LANTHEUS HOLDINGS INC
LANTHEUS HOLDINGS INC
Share · US5165441032 · LNTH · A117UE (XNMS)
Overview Financial Indicators
83,22 USD
2,05 % 1,67 USD
NASDAQ/NMS (GLOBAL MARKET) (XNAS) · Current prices and charts at MoneyPeak
09.06.2025 20:00

Current Prices from LANTHEUS HOLDINGS INC

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
LNTH
USD
09.06.2025 20:00
83,22 USD
81,55 USD
+2,05 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % 8,08 % 1,81 % -21,74 % -10,11 % 4,16 % 454,80 %

Company Profile for LANTHEUS HOLDINGS INC Share

Lantheus Holdings, Inc. develops, manufactures, and commercializes diagnostic and therapeutic products that assist clinicians in the diagnosis and treatment of heart, cancer, and other diseases worldwide. It provides DEFINITY, a microbubble ultrasound enhancing agent used in ultrasound exams of the heart; TechneLite, a technetium generator for nuclear medicine; Xenon-133 to assess pulmonary function; Neurolite to identify the area within the brain where blood flow has been blocked or reduced due to stroke; Cardiolite, an injectable Tc-99m-labeled imaging agent; Thallium-201 to detect cardiovascular disease; and Gallium-67 to detect various infections and cancerous tumors. The company also offers AZEDRA, a radiotherapeutic to treat adult and pediatric patients; Automated Bone Scan Index that calculates the disease burden of prostate cancer by quantifying the hotspots on bone scans; and Cobalt (Co 57), a non-pharmaceutical radiochemical; RELISTOR for opioid-induced constipation; and PYLARIFY for visualization of lymph nodes, bone, and soft tissue metastases to determine the presence or absence of recurrent and/or metastatic prostate cancer. It also develops flurpiridaz F 18 to assess blood flow to the heart; 1095, a PSMA-targeted iodine-131 labeled small molecule; LMI 1195 for neuroblastoma tumors in pediatric and adults; PYLARIFY AI, an AI-based medical device software to perform standardized quantitative assessment of PSMA PET/CT images in prostate cancer; and leronlimab, an investigational humanized monoclonal antibody. The company serves radio pharmacies, distributors, integrated delivery networks, hospitals, clinics, and group practices. It has strategic partnerships with NanoMab Technology Limited; Bausch Health Companies, Inc.; GE Healthcare Limited; Curium; Bayer AG; CytoDyn Inc.; ROTOP; FUJIFILM; Regeneron Pharmaceuticals, Inc.; and POINT Biopharma US Inc. The company was founded in 1956 and is headquartered in North Billerica, Massachusetts.

Company Data

Name LANTHEUS HOLDINGS INC
Company Lantheus Holdings, Inc.
Symbol LNTH
Website https://www.lantheus.com
Primary Exchange XNMS NASDAQ/NMS (GLOBAL MARKET)
WKN A117UE
ISIN US5165441032
Asset Class Share
Sector Healthcare
Industry Drug Manufacturers - Specialty & Generic
CEO Mr. Brian A. Markison
Market Capitalization 7 Mrd.
Country United States of America
Currency USD
Employees 0,8 T
Address 331 Treble Cove Road, 01862 North Billerica
IPO Date 2015-06-25

Ticker Symbols

Name Symbol
Frankfurt 0L8.F
NASDAQ LNTH

More Shares

Investors who LANTHEUS HOLDINGS INC hold also have the following shares in their portfolio:
AMGEN INC
AMGEN INC Share
APPLE INC
APPLE INC Share
AUTODESK INC
AUTODESK INC Share
CADENCE DESIGN SYSTEMS INC
CADENCE DESIGN SYSTEMS INC Share
CISCO SYSTEMS INC
CISCO SYSTEMS INC Share
COSTCO WHOLESALE CORP
COSTCO WHOLESALE CORP Share
DEA CAPITAL S.P.A.
DEA CAPITAL S.P.A. Share
LAM RESEARCH CORP
LAM RESEARCH CORP Share
MICRON TECHNOLOGIESLOGY INC
MICRON TECHNOLOGIESLOGY INC Share
NIEDERS.SCH.A.18/33 A.883
NIEDERS.SCH.A.18/33 A.883 Bond
PULTE GROUP 2035
PULTE GROUP 2035 Bond
QUALCOMM INC
QUALCOMM INC Share
SCHOELLERBK VORSORGEFDS A
SCHOELLERBK VORSORGEFDS A Fund
STARBUCKS CORP
STARBUCKS CORP Share
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025